Last Chance: Get 30 Days of MarketBeat All Access for FREE, then just $399 $199 for the year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
×
S&P 500   3,973.01 (+0.23%)
DOW   33,912.37 (+0.19%)
QQQ   282.07 (-0.23%)
AAPL   143.38 (-0.58%)
MSFT   240.66 (-0.45%)
META   109.54 (+0.70%)
GOOGL   95.11 (-0.98%)
AMZN   93.08 (-0.93%)
TSLA   183.41 (+0.27%)
NVDA   157.93 (-0.21%)
NIO   10.78 (+6.52%)
BABA   79.90 (+5.30%)
AMD   73.76 (+0.78%)
T   18.86 (+0.21%)
MU   56.08 (+0.59%)
CGC   3.43 (+0.88%)
F   13.78 (+0.36%)
GE   85.46 (-0.01%)
DIS   95.59 (-0.10%)
AMC   7.31 (-0.27%)
PYPL   80.03 (+0.13%)
PFE   49.54 (-0.06%)
NFLX   279.72 (-0.52%)
S&P 500   3,973.01 (+0.23%)
DOW   33,912.37 (+0.19%)
QQQ   282.07 (-0.23%)
AAPL   143.38 (-0.58%)
MSFT   240.66 (-0.45%)
META   109.54 (+0.70%)
GOOGL   95.11 (-0.98%)
AMZN   93.08 (-0.93%)
TSLA   183.41 (+0.27%)
NVDA   157.93 (-0.21%)
NIO   10.78 (+6.52%)
BABA   79.90 (+5.30%)
AMD   73.76 (+0.78%)
T   18.86 (+0.21%)
MU   56.08 (+0.59%)
CGC   3.43 (+0.88%)
F   13.78 (+0.36%)
GE   85.46 (-0.01%)
DIS   95.59 (-0.10%)
AMC   7.31 (-0.27%)
PYPL   80.03 (+0.13%)
PFE   49.54 (-0.06%)
NFLX   279.72 (-0.52%)
S&P 500   3,973.01 (+0.23%)
DOW   33,912.37 (+0.19%)
QQQ   282.07 (-0.23%)
AAPL   143.38 (-0.58%)
MSFT   240.66 (-0.45%)
META   109.54 (+0.70%)
GOOGL   95.11 (-0.98%)
AMZN   93.08 (-0.93%)
TSLA   183.41 (+0.27%)
NVDA   157.93 (-0.21%)
NIO   10.78 (+6.52%)
BABA   79.90 (+5.30%)
AMD   73.76 (+0.78%)
T   18.86 (+0.21%)
MU   56.08 (+0.59%)
CGC   3.43 (+0.88%)
F   13.78 (+0.36%)
GE   85.46 (-0.01%)
DIS   95.59 (-0.10%)
AMC   7.31 (-0.27%)
PYPL   80.03 (+0.13%)
PFE   49.54 (-0.06%)
NFLX   279.72 (-0.52%)
S&P 500   3,973.01 (+0.23%)
DOW   33,912.37 (+0.19%)
QQQ   282.07 (-0.23%)
AAPL   143.38 (-0.58%)
MSFT   240.66 (-0.45%)
META   109.54 (+0.70%)
GOOGL   95.11 (-0.98%)
AMZN   93.08 (-0.93%)
TSLA   183.41 (+0.27%)
NVDA   157.93 (-0.21%)
NIO   10.78 (+6.52%)
BABA   79.90 (+5.30%)
AMD   73.76 (+0.78%)
T   18.86 (+0.21%)
MU   56.08 (+0.59%)
CGC   3.43 (+0.88%)
F   13.78 (+0.36%)
GE   85.46 (-0.01%)
DIS   95.59 (-0.10%)
AMC   7.31 (-0.27%)
PYPL   80.03 (+0.13%)
PFE   49.54 (-0.06%)
NFLX   279.72 (-0.52%)

Heron Therapeutics - HRTX Earnings Date, Estimates & Call Transcripts

$2.67
-0.01 (-0.37%)
(As of 11/29/2022 10:20 AM ET)
Add
Compare
Today's Range
$2.65
$2.72
50-Day Range
$2.68
$4.67
52-Week Range
$2.19
$10.46
Volume
18,730 shs
Average Volume
2.13 million shs
Market Capitalization
$317.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.60
Skip Charts & View Estimated and Actual Earnings Data

HRTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HRTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Heron Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20221($0.30)($0.30)($0.30) 
Q2 20221($0.36)($0.36)($0.36) 
Q3 20221($0.32)($0.32)($0.32) 
Q4 20221($0.12)($0.12)($0.12) 
FY 20224($1.10)($1.10) ($1.10)

HRTX Earnings Date and Information

Heron Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 27th, 2023 based off prior year's report dates.

Heron Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/27/2023
(Estimated)
        
8/9/2022Q2 2022($0.50)($0.55)($0.05)($0.55)$24.65 million$27.63 million    
5/9/2022Q1 2022($0.45)($0.63)($0.18)($0.63)$22.61 million$23.46 million    
2/28/2022Q4 2021($0.59)($0.54)+$0.05($0.54)$25.77 million$20.66 million    
11/3/20219/30/2021($0.60)($0.51)+$0.09($0.51)$25.04 million$23.23 million    
8/9/20216/30/2021($0.56)($0.62)($0.06)($0.62)$28.44 million$22.44 million
5/10/20213/31/2021($0.57)($0.58)($0.01)($0.58)$26.00 million$20.10 million
2/24/202112/31/2020($0.65)($0.68)($0.03)($0.68)$18.38 million$20.61 million
11/5/20209/30/2020($0.63)($0.64)($0.01)($0.64)$18.00 million$19.97 million  
8/5/2020Q2 2020($0.6390)($0.6097)+$0.0293($0.61)$16.35 million$22.67 million
5/6/20203/31/2020($0.65)($0.57)+$0.08($0.57)$21.23 million$25.40 million
3/2/202012/31/2019($0.56)($0.65)($0.09)($0.65)$31.81 million$35.10 million
11/12/2019Q3 2019($0.57)($0.42)+$0.15($0.42)$34.02 million$42.62 million
8/5/2019Q2 2019($0.6480)($0.6313)+$0.0167($0.63)$31.04 million$36.66 million
5/9/20193/31/2019($0.50)($0.80)($0.30)($0.80)$28.04 million$31.60 million
2/22/2019Q4 2018($0.46)($0.63)($0.17)($0.63)$28.05 million$28.84 million
11/7/2018Q3($0.44)($0.49)($0.05)($0.49)$19.84 million$19.79 million
8/8/2018Q2 2018($0.68)($0.54)+$0.14($0.54)$12.82 million$17.28 million
5/10/20183/31/2018($0.87)($0.81)+$0.06($0.81)$11.10 million$11.60 million
2/27/2018Q4 2017($0.7950)($1.09)($0.2950)($1.09)$9.00 million$10.05 million
11/6/2017Q3 2017($0.87)($0.77)+$0.10($0.77)$8.12 million$8.57 million
8/9/2017Q2 2017($0.8990)($0.80)+$0.0990($0.80)$4.53 million$8.51 million
5/10/2017Q1 2017($0.9380)($1.00)($0.0620)($1.00)$1.96 million$3.63 million
2/23/2017Q4 2016($1.17)($1.22)($0.05)($1.22)$1.07 million$1.28 million
11/8/2016Q3 2016($1.17)($1.24)($0.07)($1.24)
8/8/2016Q2($0.96)($1.17)($0.21)($1.17)
5/5/2016Q1($0.92)($0.92)($0.92)
2/19/2016Q4($0.6370)($0.87)($0.2330)($0.87)
11/6/2015Q3($0.67)($0.63)+$0.04($0.63)
8/7/2015Q2 2015($0.65)($0.74)($0.09)($0.74)
5/8/2015Q115($0.64)($0.70)($0.06)($0.70)
3/13/2015Q4 2014($0.69)($0.71)($0.02)($0.71)
11/6/2014Q3 2014($0.69)($0.66)+$0.03($0.66)
8/4/2014Q2 2014($0.62)($0.78)($0.16)($0.78)
5/8/2014Q1 2014($0.58)($0.74)($0.16)($0.74)
3/5/2014Q4 2013($0.70)($0.75)($0.05)($0.75)
11/12/2013Q3 2013($0.80)($0.80)($0.80)
8/8/2013Q2 2013($0.80)($1.00)($0.20)($1.00)
5/10/2013Q1 2013($0.60)($0.80)($0.20)($0.80)
3/1/2013Q4 2012($0.40)($0.60)($0.20)($0.60)
11/5/2012Q3 2012($0.20)($0.40)($0.20)($0.40)
8/2/2012Q2 2012($0.40)($0.40)($0.40)
5/10/2012Q1 2012($0.40)($0.40)($0.40)
11/7/2011Q3 2011($0.42)($0.42)($0.42)
8/8/2011Q2 2011($0.94)($0.94)($0.88)
5/16/2011Q1 2011($0.66)($0.66)($0.60)
3/28/2011Q4 2010($0.76)($0.76)($0.72)
11/15/2010Q3 2010($0.82)($0.82)($0.80)
8/16/2010Q2 2010($1.88)($1.88)($1.94)
5/17/2010Q1 2010($1.46)($1.46)($2.66)
3/15/2010Q4 2009($1.22)($1.22)($1.42)
11/16/2009Q3 2009($0.80)($0.80)($0.80)
8/4/2009Q2 2009($2.54)($2.54)($2.54)
5/14/2009Q1 2009($2.00)($1.92)+$0.08($1.92)
3/31/2009Q4 2008($4.00)($2.50)+$1.50($2.44)
11/5/2008Q3 2008($4.40)($4.02)+$0.38($4.02)
8/14/2008Q2 2008($3.98)($3.98)($3.98)
5/15/2008Q1 2008($4.44)($4.44)($4.44)
3/13/2008Q4 2007($3.80)($5.00)($1.20)($5.00)












Heron Therapeutics Earnings - Frequently Asked Questions

When is Heron Therapeutics's earnings date?

Heron Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 27th, 2023 based off last year's report dates. Learn more on HRTX's earnings history.

How much revenue does Heron Therapeutics generate each year?

Heron Therapeutics (NASDAQ:HRTX) has a recorded annual revenue of $86.35 million.

How much profit does Heron Therapeutics generate each year?

Heron Therapeutics (NASDAQ:HRTX) has a recorded net income of -$220.68 million. HRTX has generated -$2.10 earnings per share over the last four quarters.

What is Heron Therapeutics's EPS forecast for next year?

Heron Therapeutics's earnings are expected to grow from ($1.85) per share to ($0.92) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:HRTX) was last updated on 11/29/2022 by MarketBeat.com Staff